Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos Hatzimouratidis

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Urology|August 2, 2014
A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunctionKonstantinos Hatzimouratidis
Current Urology Reports|November 29, 2007
Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?Konstantinos Hatzimouratidis
American Journal of Men'S Health|June 2, 2009
Epidemiology of male sexual dysfunctionKonstantinos Hatzimouratidis
Expert Opinion on Investigational Drugs|February 27, 2009
Phosphodiesterase type 5 inhibitors: a viable treatment option for lower urinary tract symptoms?Konstantinos Hatzimouratidis
Clinical Interventions in Aging|December 1, 2007
Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidenceKonstantinos Hatzimouratidis
European Urology|September 5, 2006
Phosphodiesterase type 5 inhibitors: the day afterKonstantinos Hatzimouratidis, Dimitrios Hatzichristou
Current Diabetes Reports|September 7, 2014
How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatmentKonstantinos Hatzimouratidis, Dimitrios Hatzichristou
The Journal of Sexual Medicine|January 20, 2007
Sexual dysfunctions: classifications and definitionsKonstantinos Hatzimouratidis, Dimitrios Hatzichristou
Drugs|August 3, 2005
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?Konstantinos Hatzimouratidis, Dimitrios G Hatzichristou
Drugs|January 17, 2008
Looking to the future for erectile dysfunction therapiesKonstantinos Hatzimouratidis, Dimitrios G Hatzichristou
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Urology|August 2, 2014
A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunctionKonstantinos Hatzimouratidis
Current Urology Reports|November 29, 2007
Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?Konstantinos Hatzimouratidis
American Journal of Men'S Health|June 2, 2009
Epidemiology of male sexual dysfunctionKonstantinos Hatzimouratidis
Expert Opinion on Investigational Drugs|February 27, 2009
Phosphodiesterase type 5 inhibitors: a viable treatment option for lower urinary tract symptoms?Konstantinos Hatzimouratidis
Clinical Interventions in Aging|December 1, 2007
Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidenceKonstantinos Hatzimouratidis
European Urology|September 5, 2006
Phosphodiesterase type 5 inhibitors: the day afterKonstantinos Hatzimouratidis, Dimitrios Hatzichristou
Current Diabetes Reports|September 7, 2014
How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatmentKonstantinos Hatzimouratidis, Dimitrios Hatzichristou
The Journal of Sexual Medicine|January 20, 2007
Sexual dysfunctions: classifications and definitionsKonstantinos Hatzimouratidis, Dimitrios Hatzichristou
Drugs|August 3, 2005
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?Konstantinos Hatzimouratidis, Dimitrios G Hatzichristou
Drugs|January 17, 2008
Looking to the future for erectile dysfunction therapiesKonstantinos Hatzimouratidis, Dimitrios G Hatzichristou
Pageof 6